-
Geron Corp.: A Compelling Potential Buying Opportunity Thanks To Bearish Comments
31 Mar 2025 20:52 GMT
… 's strategic direction.
yevtony Geron Corporation (NASDAQ:GERN) has only reported … by
Scientist and trader of biotech stock. Focus on trading around …
-
VC firm Vivo Capital outlays $740m for biotech investment
08 May 2025 12:15 GMT
… finance small- and mid-cap biotechnology and life science companies. … and limited gastrointestinal side effects. Geron Corporation, Avadel Pharmaceuticals, and Soleno Therapeutics … Vivo Capital outlays $740m for biotech investment" was originally …
-
Biotech giant Geron Crop accused of false Rytelo hype
15 Mar 2025 03:58 GMT
Geron Corp., a multibillion-dollar Foster City biotech company specializing in drugs that …
-
Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development
11 Nov 2024 21:42 GMT
Geron Corporation (Nasdaq: GERN), a commercial-stage … organizations at two clinical-stage biotech companies, Dragonfly Therapeutics, where he …
-
Bracane Company’s Dr. Pamela Nelson Moderates Empowering ‘Leading Women in Biotech’ Panel at Texas BioLife Summit
01 Mar 2025 19:22 GMT
… female leadership in shaping the biotechnology landscape.
Moderated by Dr. … Kaitlin Roberson (Cacti), Brandie Jonas (Geron Corporation), and Elina Lavit (Veltera). These … , a premier gathering for the biotechnology, medtech, and healthcare industries, …
-
10 Best Biotech Stocks To Buy Under $20
06 Oct 2024 11:37 GMT
… National Security Commission on Emerging Biotechnology is developing policy recommendations … , more researchers can leverage biotechnology for agricultural applications, supporting … August 2025. Analysts have given Geron Corporation (NASDAQ:GERN) stock a …
-
Geron Corporation (NASDAQ:GERN) Q3 2023 Earnings Call Transcript
03 Nov 2023 13:21 GMT
… November 2, 2023
Geron Corporation beats earnings expectations. … company’s research in biotechnology.
Actual events or … A Session Follow Geron Corp (NASDAQ:GERN) Follow Geron Corp (NASDAQ:GERN … organizational needs of a biotech company, preparing to …
-
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy
07 Jun 2024 17:00 GMT
… hematologic malignancies (myelodysplastic syndromes) from Geron Corporation.
“MAIA is one of the … the identifier NCT05208944.
About MAIA Biotechnology, Inc.
MAIA is a targeted … ,” and “us” refers to MAIA Biotechnology, Inc. and its subsidiaries.
View …
-
Opinion: Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress
27 Jun 2025 17:44 GMT
… Gammack, Chief Executive Officer, Ansa Biotechnologies, Inc.
Deborah Geraghty, Chief Executive … Officer, Nkarta Inc., Rekha Hemrajani Biotech, board member, multiple companies
… Chair and Chief Executive Officer, Geron Corporation
Rachel Sha, Chief Executive …
-
Geron Corporation (NASDAQ:GERN) Q4 2022 Earnings Call Transcript
20 Mar 2023 07:42 GMT
… welcome everyone to the Geron Corporation’s Fourth Quarter … everyone. Welcome to the Geron Corporation fourth quarter and year … a fully integrated commercial biotech company over the … A Session
Follow Geron Corp (NASDAQ:GERN) Follow Geron Corp (NASDAQ:GERN) …
About
© 1995-2025